Non-small cell lung cancer stage IIIB

Clinical trials for Non-small cell lung cancer stage IIIB explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer stage IIIB trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer stage IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental lung cancer vaccine trial halted early

Disease control Stopped early

This early-stage trial tested an experimental immunotherapy called IMU-201 (PD1-Vaxx) in 24 adults with advanced non-small cell lung cancer. The treatment was given alone or combined with another immunotherapy drug (atezolizumab) and sometimes chemotherapy. The goal was to check …

Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIB

Phase 1 • Sponsor: Imugene Limited • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

Non-small cell lung cancer stage IIIB

Get alerted when new Non-small cell lung cancer stage IIIB trials appear

Experimental lung cancer vaccine trial halted early